Patents - stay tuned to the technology

Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


14th week of 2009 patent applcation highlights part 44
Patent application numberTitlePublished
20090088431Heteroaromatic Compounds as Inhibitors of Stearoyl-Coenzyme a Delta-9 Desaturase - Heteroaromatic compounds of structural formula (I) are selective inhibitors of stearoyl-coenzyme A delta-9 desaturase (SCD1) relative to other known stearoyl-coenzyme A desaturases. The compounds of the present invention are useful for the prevention and treatment of conditions related to abnormal lipid synthesis and metabolism, including cardiovascular disease, such as atherosclerosis; lipid disorders; obesity; diabetes; neurological disease; metabolic syndrome; insulin resistance; fatty liver disease and cancer.2009-04-02
20090088432Thiazolinones and Oxazolinones and their Use as Ptp1b Inhibitors - The present invention encompasses; the novel substituted heterocyclic compounds represented by formula (I) or their pharmaceutically acceptable salts, wherein the substituents in formula (I) have the meanings as defined in the specification. The invention also encompasses process for preparing such compound, pharmaceutical compositions and methods of treating or preventing PTP-1B mediated diseases.2009-04-02
20090088433METHODS OF USING AS ANALGESICS 1-BENZYL-1-HYDROXY-2,3-DIAMINO-PROPYL AMINES, 3-BENZYL-3-HYDROXY-2-AMINO-PROPIONIC ACID AMIDES AND RELATED COMPOUNDS - The compounds shown by the structural formulas below have analgesic effect and are used in compositions and methods for treating mammal in need of such treatment.2009-04-02
20090088434Antifungal Composition - The invention provides a topical liquid antifungal composition containing an antifungal agent, a film-forming agent and a solvent. The composition is applied on the infected skin area to form a film that delivers the active agent. The invention also provides a method for treating a fungal infection on the skin by applying the topical antifungal composition that forms a film on the skin.2009-04-02
20090088435METHODS AND COMPOUNDS FOR TREATING RETINOL-RELATED DISEASES - Compounds that reduce serum retinol levels are used to treat ophthalmic conditions associated with the overproduction of waste products that accumulate during the course of the visual cycle. We describe methods, compounds, and compositions to treat, for example, the macular degenerations and dystrophies or to alleviate symptoms associated with such ophthalmic conditions.2009-04-02
20090088436P38 Kinase Inhibiting Agents - Compounds described by the chemical formula (I) or pharmaceutically acceptable salts thereof:2009-04-02
20090088437INDOLES, 1H-INDAZOLES, 1,2-BENZISOXAZOLES, AND 1,2-BENZISOTHIAZOLES, AND PREPARATION AND USES THEREOF - The present invention relates generally to the field of ligands for nicotinic acetylcholine receptors (nAChR), activation of nAChRs, and the treatment of disease conditions associated with defective or malfunctioning nicotinic acetylcholine receptors, especially of the brain. Further, this invention relates to novel compounds for example, indoles, 1H-indazoles, 1,2-benzisoxazoles, and 1,2-benzisothiazoles, which act as ligands for the α7 nAChR subtype, methods of preparing such compounds, compositions containing such compounds, and methods of use thereof.2009-04-02
20090088438NEW TYROSINE DERIVATIVES AS PPARy MODULATORS - Compounds of general formula I,2009-04-02
20090088439Diazinane Compounds - The present invention relates to novel compounds of the general formula (I)2009-04-02
20090088440DERIVATIVES OF 5-PYRIDAZINYL-1-AZABICYCLO[3.2.1]OCTANE, PREPARATION METHOD THEREOF AND USE OF SAME IN THERAPEUTICS - The invention relates to compounds having general formula (I), wherein R is as defined herein.2009-04-02
20090088441Quinoline Compounds - The present invention relates to novel compounds of the general formula (I)2009-04-02
20090088442PROPHYLACTIC/THERAPEUTIC AGENT FOR ABNORMALITIES OF SUGAR/LIPID METABOLISM - The present invention provides a pharmaceutical agent for the treatment and/or prophylaxis of abnormal blood glucose and lipid metabolism associated with eating, for which a sufficient treatment method or a therapeutic drug has not been found.2009-04-02
20090088443NOVEL CRYSTALLINE FORMS OF CONAZOLES AND METHODS OF MAKING AND USING THE SAME - The invention provides novel soluble conazole crystalline forms (e.g. itraconazole, posaconazole and saperconazole) that include salts, co-crystals and related solvates useful as pharmaceuticals. The invention also provides pharmaceutical compositions comprising, and processes for making, these conazole crystalline forms. Methods of using such compositions for the treatment or prevention of systemic and local fungal, yeast, and dermatophyte infections are also provided.2009-04-02
20090088444Substituted phenanthrene diketo acids and uses therefor - Provided herein are substituted phenanthrene diketo acid compounds. These compounds comprise the diketo acid moiety on one of carbons C1-C4 and C9 in the phenanthrene ring and at least one further substitutent on the other ring carbons. Also provided are methods of inhibiting an activity of a human immunodeficiency virus (HIV) integrase protein and treating an HIV infection in a subject using the substituted phenanthrene diketo acid compounds.2009-04-02
20090088445Deazapurines useful as inhibitors of Janus kinases - The present invention relates to compounds useful as inhibitors of protein kinases, particularly of JAK family kinases. The invention also provides pharmaceutically acceptable compositions comprising said compounds and methods of using the compositions in the treatment of various disease, conditions, or disorders.2009-04-02
20090088446PURINONE DERIVATIVES AS HM74A AGONISTS - The present invention relates to purinone derivatives which are agonists of the HM74a receptor. Further provided are compositions and methods of using the compounds herein, and their pharmaceutically acceptable salts for the treatment of disease.2009-04-02
20090088447SOLID FORMS OF (S)-ETHYL 2-AMINO-3-(4-(2-AMINO-6-((R)-1-(4-CHLORO-2-(3-METHYL-1H-PYRAZOL-1-YL)PHEN- YL)-2,2,2-TRIFLUOROETHOXY)-PYRIMIDIN-4-YL)PHENYL)PROPANOATE AND METHODS OF THEIR USE - Solid forms of (S)-ethyl 2-amino-3-(4-(2-amino-6-((R)-1-(4-chloro-2-(3-methyl-1H-pyrazol-1-yl)phenyl)-2,2,2-trifluoroethoxy)pyrimidin-4-yl)phenyl)propanoate and salts thereof are disclosed.2009-04-02
20090088448Rapamycin Derivatives and the Uses Thereof in the Treatment of Neurological Disorders - Provided is a method of treating neurodegenerative disorders comprising administering to a subject in need thereof a compound of formula I:2009-04-02
200900884494-ACYLAMINOPYRIDINE DERIVATIVE MEDIATED NEUROGENESIS - The instant disclosure describes methods for treating diseases and conditions of the central and peripheral nervous system by stimulating or increasing neurogenesis. The invention includes methods based on use of a 4-acylaminopyridine derivative to stimulate or activate the formation of new nerve cells.2009-04-02
200900884505-ht7 receptor antagonists - The invention relates to compounds having pharmacological activity towards the 5-HT7 receptor, and more particularly to some tetrahydroisoquinoline propyl sulfonamide compounds, to processes of preparation of such compounds, to pharmaceutical compositions comprising them, and to their use for the treatment and or prophylaxis of a disease in which 5-HT is involved, such as CNS disorders.2009-04-02
20090088451QUINOLINES - The present invention relates to 2-aminoquinolines of formula I2009-04-02
20090088452Indole Orexin Receptor Antagonists - The present invention is directed to substituted indole compounds which are antagonists of orexin receptors, and which are useful in the treatment or prevention of neurological and psychiatric disorders and diseases in which orexin receptors are involved. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which orexin receptors are involved.2009-04-02
20090088453BIPHENYL COMPOUNDS USEFUL AS MUSCARINIC RECEPTOR ANTAGONISTS - This invention provides compounds of formula I:2009-04-02
20090088454ANTI-CANCER COMPOUNDS - The invention provides bradykinin antagonists and pharmaceutically acceptable salts thereof having anti-cancer activity. These anti-cancer compounds are particularly useful for inhibiting the growth of lung and prostate cancers.2009-04-02
20090088455Chronic, Bolus Adminstration Of D-Threo Methylphenidate - Chronic bolus administration of D-threo methylphenidate is provided. The administration of the D-threo isomer eliminates adverse side effects associated with the DL racemate, and provides improved effectiveness. The compositions and methods of the invention are useful in treating nervous system disorders including attention deficit disorder, attention deficit hyperactivity disorder, and cognitive decline associated with systemic diseases such as acquired immunodeficiency syndrome.2009-04-02
200900884562-Pyridinylethylcarboxamide derivatives and their use as Fugicides - A compound of general formula (I)2009-04-02
20090088457Primary Amines as Renin Inhibitors - The invention relates to novel primary amine derivatives and the use thereof as active ingredients in the preparation of pharmaceutical compositions. The invention also concerns related aspects including processes for the preparation of the compounds, pharmaceutical compositions containing one or more of those compounds and especially their use as inhibitors of renin.2009-04-02
20090088458N-(Pyridin-4-Yl)-2-Phenylbutanamides as Androgen Receptor Modulators - Compounds of structural formula I are modulators of the androgen receptor (AR) in a tissue selective manner. These compounds are useful in the enhancement of weakened muscle tone and the treatment of conditions caused by androgen deficiency or which can be ameliorated by androgen administration, including osteoporosis, osteopenia, glucocorticoid-induced osteoporosis, periodontal disease, bone fracture, bone damage following bone reconstructive surgery, sarcopenia, frailty, aging skin, male hypogonadism, postmenopausal symptoms in women, atherosclerosis, hypercholesterolemia, hyperlipidemia, obesity, aplastic anemia and other hematopoietic disorders, inflammatory arthritis and joint repair, HIV-wasting, prostate cancer, benign prostatic hyperplasia (BPH), abdominal adiposity, metabolic syndrome, type II diabetes, cancer cachexia, Alzheimer's disease, muscular dystrophies, cognitive decline, sexual dysfunction, sleep apnea, depression, premature ovarian failure, and autoimmune disease, alone or in combination with other active agents.2009-04-02
20090088459NOVEL BIARYL SULFONAMIDE DERIVATIVES - The invention is concerned with novel biaryl sulfonamide derivatives of formula (I)2009-04-02
20090088460Administration of E-3[3-[N-(4-methoxybenzenesulfonyl)-N-isopropylamino]phenyl]-3-(3-pyridyl- )propenohydroxamic acid for preventing and/or treating inflammatory cutaneous pathologies/afflictions - Inflammatory cutaneous pathologies/afflictions, e.g., eczema or psoriasis, are prevented and/or treated by administering to a subject in need of such treatment, a thus effective amount of E-3-[3-[N-(4-methoxybenzenesulfonyl)-N-isopropylamino]phenyl]-3-(3-pyridyl)propenohydroxamic acid of formula (I):2009-04-02
20090088461Methods of Treating or Preventing Cardiac Disease Associated With a High Fat Diet - The present invention relates to a method of treating or preventing cardiac disorders, myocardial inflammation or myocardial oxidative stress associated with a high fat diet or in a patient subjected to a high fat diet using the thiazolium compounds and compositions of the invention. The present invention also relates to a method of ameliorating weight gain, myocardial AGE accumulation associated, mitochondrial superoxide production, RAGE expression or PPARα expression with a high fat diet or in a patient subjected to a high fat diet using the thiazolium compounds and compositions of the invention.2009-04-02
20090088462Pharmaceutical Composition for Enhancing Adiponectin Production - Method for treatment of a human patient having hypoadiponectinemia. 5-[4-(6-methoxy-1-methyl-1H-benzimidazol-2-ylmethoxy)benzyl]thiazolidine-2,4-dione or a pharmacologically salt thereof is administered in an amount effective to raise the level of adiponectine in said patient.2009-04-02
20090088463Pyrazoles Useful in the Treatment of Inflammation - There is provided compounds of formula (I), wherein X2009-04-02
20090088464Merged ion channel modulating compounds and Uses Thereof - Merged compounds of ion channel modulating compounds, including, for example, merged compounds of the ion channel modulating compound of the following formula: (I) are described herein, as well as methods of making and using such merged compounds and pharmaceutical compositions containing such merged compounds.2009-04-02
20090088465Pharmaceutical Compositions of Amorphous Atorvastatin and Process for Preparing Same - Solid pharmaceutical compositions containing atorvastatin are disclosed. The compositions include a solid dispersion of amorphous atorvastatin and one or more optional pharmaceutically acceptable excipients. The solid dispersion is prepared by mixing crystalline atorvastatin with a melt-processable polymer and an optional stabilizer at a temperature sufficiently high to soften or melt the polymer and to melt or dissolve the crystalline atorvastatin in the polymer, thereby forming a dispersion of amorphous atorvastatin.2009-04-02
20090088467VITAMIN E SUPPLEMENTATION TO TETANUS TOXOID - The invention relates to a formulation for supplementation on immune response to a biological substance. More particularly, the formulation consists of one or more forms of Vitamin E which provides a supplementation on immune response to tetanus toxoid. In addition, the present invention also relates on the effect of different types of Vitamin E such as tocotrienol rich fraction, delta tocotrienol and alpha-tocopherol supplementation on immune response to tetanus toxoid vaccination.2009-04-02
20090088468NOVEL EPOPROSTENOL FORMULATION AND METHOD OF MAKING THEREOF - This invention relates to a stable epoprostenol composition that can be combined with commercially available IV fluids and can be administered in its reconstituted and/or diluted form under ambient conditions of about 15-30° C. for greater than 24 hours. The composition preferably contains (a) epoprostenol or a salt thereof; (b) a alkalinization agent; and (c) a base, such that when reconstituted or in solution, the solution has a pH>11. Methods for making the lyophilized composition are also disclosed.2009-04-02
20090088469METHOD FOR THE PREPARATION OF CITALOPRAM - Method for the preparation of citalopram comprising reaction of a compound of Formula (IV) wherein R is halogen, or CF2009-04-02
20090088470ALKYL-, ALKENYL- AND ALKYNYLCARBAMATE DERIVATIVES, THEIR PREPARATION AND THEIR APPLICATION IN THERAPEUTICS - The invention relates to a compound of formula (I):2009-04-02
20090088471Chemical sterilant for adult male dog population control with concomitant reduction in human dog-bite acquired rabies - A chemical composition for use in controlling the population of free-roaming, sexually mature male dogs. The chemical sterilant is injected in a manner that the dog's appearance and secondary male sexual characteristics are preserved such that the dog maintains its position in the hierarchy of the free-roaming dogs while not contributing to the number of puppies produced. A reduction in the number of free-roaming dogs reduces the number of human victims of dog-bite acquired rabies. Because the appearance and nature of the sterilized dog is substantially unchanged, the chemical composition is acceptable to the human community that the dog habitats.2009-04-02
20090088472Protective Agent for Neuronal Cell Comprising Amidino Derivative as Active Ingredient - An object of the present invention is to provide a protective agent for a neuronal cell. The protective agent for a neuronal cell according to the present invention contains a compound represented by the following general formula [I] or a salt thereof as an active ingredient. In the formula, R2009-04-02
20090088473METHOD FOR SCREENING OF PROSTAGLANDIN COMPOUNDS COMPRISING AN OPTIMAL FORMULATION FOR THE ENHANCEMENT OF HAIR GROWTH AND THE STIMULATION OF FOLLICULAR ANAGEN AND FORMULATIONS RESULTING THEREFROM - A method for developing Prostaglandin F2009-04-02
20090088474USE OF SUBSTITUTED CYCLOPROPANE ACID DERIVATIVES FOR PRODUCING DRUGS FOR USE IN THE TREATMENT OF METABOLIC SYNDROME - The present invention comprises methods for reducing plasma lipids, plasma free fatty acids (FFA), plasma glycerol and triglycerides in a mammal through the administration of certain substituted cyclopropane acid derivatives of Formula 1:2009-04-02
20090088475Indanone derivatives that inhibit prolyl hydroxylase - Compounds of Formula I are useful inhibitors of HIF prolyl hydroxylases. Compounds of Formula I have the following structure:2009-04-02
20090088476Dental irrigant - An irrigant comprising either a hypochlorite compound or a chlorhexidine compound in combination with at least one surfactant and preferably two or more surfactants, including fluorosurfactants, ethoxylates, sulfonates, quaternary ammonium compounds, amine oxides, and combinations thereof, wherein each of the surfactants are capable of complexing with one another.2009-04-02
20090088477Compounds and methods for leukotriene biosynthesis inhibition - This invention provides novel salt and crystalline forms thereof of (−)4-(4-fluorophenyl)-7-[({5-[1-hydroxy-1-(trifluoromethyl)propyl]-1,3,4-oxadiazol-2-yl}amino)-methyl]-2H-chromen-2-one. The compounds are 5-LO inhibitors and are useful for treatment of conditions such as asthma, allergic rhinitis, COPD, and atherosclerosis.2009-04-02
20090088478NOVEL COMPOUNDS AS HISTONE DEACETYLASE INHIBITORS - The present invention relates to compounds as inhibitors of enzymes having histone deacetylase activity, to the processes for the preparation of those compounds, and to their use for the treatment of diseases which are associated with hypoacetylation of histones and/or other molecules, or in which induction of hyperacetylation has a beneficial effect for example by inhibition of proliferation and/or induction of differentiation and/or induction of apoptosis in transformed cells, such as cancer. Furthermore, the compounds are useful for the treatment of other proliferative diseases, for therapy or prophylaxis of conditions associated with abnormal gene expression.2009-04-02
20090088479SALT OF ALISKIREN WITH SULFURIC ACID - The invention relates to a new salt of aliskiren, the respective production and usage, and pharmaceutical preparations containing such a salt.2009-04-02
20090088480SOLID FORMS OF SELECTIVE ANDROGEN RECEPTOR MODULATORS - The present invention relates to solid forms of (S)—N-(4-cyano-3-(trifluoromethyl)phenyl)-3-(4-cyanophenoxy)-2-hydroxy-2-methylpropanamide and process for producing the same.2009-04-02
20090088481Method of Protecting Wood Through Enhanced Penetration of Wood Preservatives and a Related Solution - A method of protecting wood through enhanced penetration of wood preservatives includes providing a solution including (a) at least one amine oxide, (b) at least one organic wood preservative and (c) a buffering agent. The solution preferably has a pH of about 7 to 10. The solution is applied to the surface of the wood after which, with or without intervening storage, the materials are activated to effect enhanced penetration of the organic wood preservative into the wood. One may effect application at a solution temperature of about 30 to 75° C. and preferably about 50 to 60° C. to effect activation at a higher temperature and high relative humidity. In a preferred practice, the wood may be heated before and/or after application of the solution. The solution is also disclosed as a product.2009-04-02
20090088482Compositions and Methods For Treating Heart Failure - The present invention provides compositions and methods for the following: preventing and treating heart failure; preventing heart failure in a patient with a pre-heart failure condition; treating and preventing heart failure with ischemic and non-ischemic causes; treating and preventing heart failure in a subject status post myocardial infarction; reversing damage to the heart following myocardial infarction; by administering to a subject an effective amount of an adrenergic beta-agonist either alone or in combination with an effective amount of an adrenergic beta-1 antagonist. FIG. 2009-04-02
20090088483AQUEOUS SUSPENSIONS OR DISPERSIONS OF INORGANIC PIGMENTS CONTAINING A MIXTURE CONSISTING OF DIALDEHYDES AND FORMALDEHYDE CLEAVERS - The invention relates to aqueous suspensions or dispersions (slurries) of minerals and/or fillers and/or pigments containing one or more dialdehydes and one or more formaldehyde cleavers, and to the use of mixtures consisting of one or more dialdehydes and of one or more formaldehyde cleavers for stabilizing aqueous suspensions or dispersions of minerals and/or fillers and/or pigments (slurries) with regard to infestation or deterioration by microorganisms.2009-04-02
20090088484NITRIC OXIDE (NO)-RELEASING POLYMERS AND COMPOUNDS AND USES THEREOF - The invention provides compositions that are NO-releasing polymers or low-molecular-weight NO-releasing compounds. The invention also provides the secondary amine polymers that are the precursors as well as the products of the NO-releasing polymers. The invention provides methods of making the secondary amine polymer precursors and the NO-releasing polymers. The invention provides methods for the nitrosation of low-molecular-weight amines and secondary amine polymers to form the corresponding low-molecular-weight NO-releasing compounds and polymers.2009-04-02
20090088485Method for controlling foaming in a process - The invention is a method for controlling foaming in a process, the method comprising the steps of: (a) withdrawing process liquid from the process and generating gas bubbles in the process liquid by contacting the process liquid with bubble gas; (b) measuring individual lifetimes of the gas bubbles to obtain bubble lifetime data; (c) using the bubble lifetime data to predict the foam-forming tendency of the process liquid; (d) if the bubble lifetime data indicate that excess foaming will occur, adjusting the process to prevent excess foaming.2009-04-02
20090088486ECONOMICALLY EFFICIENT PROCESS OF SYNTHESIZING POROUS POLYMERIC MATERIALS - The present invention provides processes for the synthesis of porous polymeric materials. The processes provide low cost and/or less complicated methods of controlling pore size distribution in polymeric materials.2009-04-02
20090088487FILLER COMPOSITION - A filler composition comprising one or more ester-containing compounds and one or more ether-containing compounds.2009-04-02
20090088488Use of linear siloxanes and process for their preparation - The invention relates to the use of a composition comprising at least one compound of the general formula (I)2009-04-02
20090088489AMINE CATALYSTS SUITABLE FOR PRODUCING LOW-EMANATION, RECATALYSIS-STABLE FLEXIBLE POLYURETHANE FOAMS - The present invention relates to the use of a reactive amine catalyst, in particular diethylaminoethoxyethanol and/or diethylethanolamine, in aqueous or organic solutions for producing flexible polyurethane foams having an increased recatalysis stability, and also a catalyst combination containing at least one reactive amine catalyst which can be used according to the invention; and at least one organic potassium, tin, bismuth and/or zinc compound; and/or at least one tertiary amine selected from the group consisting of triethylenediamine, triethylamine and/or silamorpholine; and/or at least one acid-blocked derivative of a tertiary amine.2009-04-02
20090088490TWO-PHOTON ABSORPTION RECORDING MATERIAL CONTAINING DYE HAVING POLYMERIZABLE GROUP - A simultaneous two-photon absorption three-dimensional recording material includes at least one kind of dye having at least one polymerizable group.2009-04-02
20090088491PHOTO-CURABLE COMPOSITION INCLUDING POLYMERIZABLE COMPOUND, POLYMERIZATION INITIATOR, AND DYE - The invention provides a photo-curable composition that addresses degradation in dispersibility caused by the use of a pigment, and has good color tone and high light fastness. The photo-curable composition includes: a polymerizable compound; a polymerization initiator; and a dye represented by Formula (1):2009-04-02
20090088492INK COMPOSITION - The invention provides an ink composition including (a) a tertiary amine compound having a cationically polymerizable group, (b) a photo-acid generator, and (c) a cationically polymerizable compound. According to the invention, an ink composition in which generation of tackiness on the surface of an image formed is effectively suppressed while maintaining curing sensitivity to irradiation with a radiation ray, blocking is not generated even in the case of laminating prints after image formation, and ejecting property in applying to an inkjet apparatus is good can be provided.2009-04-02
20090088493OPHTHALMIC AND OTORHINOLARYNGOLOGICAL DEVICE MATERIALS CONTAINING AN ALKYLPHENOL ETHOXYLATE - Disclosed are soft, high refractive index, acrylic device materials. The materials contain a functionalized alkylphenol ethoxylate to reduce glistenings.2009-04-02
20090088494SOLID MATERIALS OBTAINABLE BY RING-OPENING METATHESIS POLYMERIZATION - The invention describes solid materials, especially for dental purposes like, e.g., composite milling blocks (CMBs), which can be obtained by ring-opening metathesis polymerization (ROMP). Also described is a method for obtaining such milling blocks, their use and applications of the compositions.2009-04-02
20090088495FLAME-RETARDANT PARTICLE, RESIN COMPOSITION AND RESIN FORMED BODY - A flame-retardant particle includes: a particle containing a compound having a structure represented by formula (1); and a coating particle that covers at least a part of a surface of the particle:2009-04-02
20090088496METHOD FOR PRODUCING RUBBER-FILLER COMPOSITE - A rubber-filler composite exhibiting low heat build-up, fatigue resistance and heat aging resistance equal to those of a concentrated natural rubber latex, despite using a field latex of a natural rubber and omitting a concentration step is disclosed. The rubber-filler composite is obtained by jetting a field latex of a natural rubber in a form of a high-speed flow having a flow rate of 500 m/sec or more into a mixing chamber while supplying a filler slurry containing a filler to the mixing chamber, thereby separating and removing protein in the field latex from a rubber component and at the same time, mixing the field latex and the filler slurry.2009-04-02
20090088497PAVING MATERIAL AND METHOD FOR CONSTRUCTION OF PAVED BODY USING THE SAME - The purposes of the present invention are to provide a paving material which is easy to be handled, has less restriction on the conditions of execution of work, decomposes fast, and is superior in durability, and a method for construction of paved body using the paving material. The purposes are attained by providing a paving material and a method for construction of paved body using the same, said paving material comprises at least binder emulsion for pavement, non-water soluble epoxy resin, and amine compound(s) a hardener thereof, and is prepared by mixing these three ingredients at the time of the execution of work, at the scene of the execution of work. The purposes are also attained by providing binder emulsion for pavement comprising an amine compound(s) that is a hardener of epoxy resin and the amine compound comprises at least polyaminoamido.2009-04-02
20090088498Printing ink base material - The invention is a water-based base material for printing inks, as well as a method for making the same, where the printing inks are primarily for use in flexographic or rotogravure printing, where the base material comprises blend vehicle and a dextrin. Additional components may be added, including but not limited to a drying retarder, a defoamer, a coalescing agent, a dispersant, water, one or more pigments or dyes, inert materials, and other materials known by those of ordinary skill in the art.2009-04-02
20090088499BITUMINOUS PRODUCTS, THE MIXTURE THEREOF WITH AGGREGATES AND THE USE THEREOF - The invention relates to anhydrous bituminous products containing one or several specific additives which make it possible to substantially reduce a temperature for producing aggregate and bituminous product mixtures in such a way that it ranges from 20 to 40° C., wherein the temperature of the aggregate and the bituminous product mixture during spreading ranges from 10 to 40° C. and the temperature in the core of the aggregate and bituminous product mixtures during compacting can be raised to 50° C. without degrading the standardized properties of the bituminous product and the bituminous product and aggregate mixture and ensuring the process continuity from transport to compacting according to the state of the art. The inventive aggregate and bituminous product mixtures are particularly suitable for tightening, building and servicing road surfaces, pavements and airfield runways.2009-04-02
20090088500OIL-BASED INK COMPOSITION - An oil-based ink composition comprising a colorant, an organic solvent and a polymeric compound, and optionally an alkylamine ethylene oxide derivative as a pH adjusting agent, in which the pH of an aqueous phase is from 5.5 to 10, when ions in the ink composition are transferred to water. This oil-based ink composition prevents corrosion of a nozzle plate and is improved in storage stability, and thus can ensure printer reliability such as ink-jet stability obtainable even after long storage thereof, and can withstand outdoor service environments.2009-04-02
20090088501FLAME-RETARDANT POLY(ARYLENE ETHER) COMPOSITION AND ITS USE AS A COVERING FOR COATED WIRE - A flame retardant poly(arylene ether) composition is described. In addition to the poly(arylene ether), the composition includes a polyolefin component, and a flame retardant composition that includes a metal dialkyl phosphinate, a nitrogen-containing flame retardant, and a liquid triaryl phosphate. The polyolefin component can be a polyolefin polymer and/or the polyolefin block of a poly(alkenyl aromatic)-polyolefin block copolymer. The composition is particularly suitable as a replacement for poly(vinyl chloride) in insulation for wire and cable.2009-04-02
20090088502FLAME-RETARDANT POLY(ARYLENE ETHER) COMPOSITION AND ITS USE AS A COVERING FOR COATED WIRE - A flame retardant poly(arylene ether) composition is described. In addition to the poly(arylene ether), the composition includes a polyolefin component, and a flame retardant composition that includes a metal dialkyl phosphinate and a nitrogen-containing flame retardant but excludes a liquid triaryl phosphate. The polyolefin component can be a polyolefin polymer and/or the polyolefin block of a poly(alkenyl aromatic)-polyolefin block copolymer. The composition is particularly suitable as a replacement for poly(vinyl chloride) in insulation for wire and cable.2009-04-02
20090088503Flame-Retardant Polyester Resin Composition - The present invention is intended to provide a non-halogen flame-retardant polyester resin composition that has a high level of low warping properties and is capable of providing a molded product free from sticky residue in which the bleed-out of the flame retardant is suppressed even when the molded product is exposed to a high temperature environment. The flame-retardant polyester resin composition, having a high level of low warping properties and capable of providing a molded product free from sticky residue in which the bleed-out of the flame retardant is suppressed even when the molded product is exposed to a high temperature environment, can be obtained by incorporating an organic phosphorus-based flame retardant represented by the following general formula (1) and an amorphous resin at a specific ratio relative to a thermoplastic polyester resin.2009-04-02
20090088504HIGH HEAT POLYCARBONATES, METHODS OF MAKING, AND aRTICLES FORMED THEREFROM - Disclosed herein is a polymer blend comprising a first polycarbonate comprising a first structural unit derived from a 2-aryl-3,3-bis(4-hydroxyaryl)phthalimidine and a second structural unit derived from a dihydroxy aromatic compound, wherein the second structural unit is not identical to the first structural unit, and a second polycarbonate comprising a structural unit derived from a dihydroxy aromatic compound, wherein the polymer blend has a glass transition temperature of 155 to 200° C.; and wherein a test auricle having a thickness of 3.2 mm and molded from the blend has a haze of less than or equal to 3.0 measured in accordance with ASTM D1003-00. A method of making the polymer blend, and articles prepared from the blend, are also disclosed.2009-04-02
20090088505MOLDING DOPE - The object of this invention is to provide a dope containing a polyamide having a hydroxyl-group-possessing aromatic ring, which exhibits optical anisotropy and has excellent formability, and the dope contains a polymer having a recurring unit of the following formula (I),2009-04-02
20090088506SYNTHESIS OF ENERGETIC THERMOPLASTIC ELASTOMERS CONTAINING BOTH POLYOXIRANE AND POLYOXETANE BLOCKS - This thermoplastic elastomer is present in a substantially solid state suitable for use as a binder for a propellant, explosive, and/or gas generant of a supplemental restraint system. The thermoplastic elastomer is formed from a composition including A blocks which are crystalline at temperatures below about 75° C. and B blocks which are amorphous at temperatures above about −20° C. The A blocks are derived from oxetane derivatives and the B blocks are derived from oxiranes and derivatives thereof. The A blocks and B blocks are end-capped with a diisocyanate having a first isocyanate moiety that is substantially more reactive with the terminal groups of the blocks than the second isocyanate moiety, whereby the more reactive first isocyanate moiety is capable of reacting with the terminal groups of the blocks, leaving the less reactive second isocyanate moiety free and unreacted. The end-capped A blocks and the end-capped B blocks are linked together with a linking compound having two isocyanate-reactive groups which are sufficiently unhindered to react with the free and unreacted isocyanate moieties of the end-capped polymers.2009-04-02
20090088507Resin composition for reflector, and reflecrtor - To provide a polyamide resin composition for reflectors, which gives a molding having high mechanical strength and excellent heat resistance and stably having a high reflectance and can give a reflector rarely suffering lowering of reflectance caused by heating particularly in a LED production process and a reflow soldering process, and a reflector obtained by molding the resin composition. The polyamide resin composition for reflectors of the invention comprises 30 to 80% by weight of a polyamide resin (A), 10 to 60% by weight of an inorganic filler (B) and 5 to 50% by weight of a white pigment (C) (with the proviso that the total of the components (A), (B) and (C) does not exceed 100% by weight), and is characterized in that the polyamide resin (A) comprises dicarboxylic acid component units (a-1) comprising 30 to 100% by mol of dicarboxylic acid component units derived from terephthalic acid and 0 to 70% by mol of component units derived from an aromatic dicarboxylic acid other than terephthalic acid and/or 0 to 70% by mol of component units derived from an aliphatic dicarboxylic acid of 4 to 20 carbon atoms, and diamine component units (a-2) comprising component units derived from a straight-chain aliphatic diamine of 4 to 20 carbon atoms and/or component units derived from an aliphatic diamine having a side chain and having 4 to 20 carbon atoms, and the polyamide resin (A) has a terminal amino group concentration of 70 to 230 mmol/kg.2009-04-02
20090088508POWDERY COMPOSITION OF A POLYMER AND A FLAMEPROOFING AGENT CONTAINING AMMONIUM POLYPHOSPHATE, METHOD FOR THE PRODUCTION THEREOF, AND MOULDED BODY PRODUCED FROM SAID POWDER - The present invention relates to a powder which, in addition to a polymer, comprises a flame retardant based on ammonium polyphosphate, to the use of this powder for the layer-by-layer production of moldings, and also to moldings produced from this powder. The moldings constructed using the inventive powder have marked advantages with regard to their flammability, when comparison is made with conventional products, and this permits use in aircraft, for example.2009-04-02
20090088509COPOLYCARBONATE COMPOSITIONS - A copolycarbonate composition is provided comprising a blend of a polycarbonate-polysiloxane copolymer and a terephthalate polymer. The blend has a combination of good melt volume rate, good fatigue resistance, and high ductility at low temperatures.2009-04-02
20090088510Thermoplastic polyolefin material with high surface gloss - A compound is described including one or more polymer (A) selected from propylene-ethylene block copolymers (A1), propylene homopolymers (A2) and a combination of copolymers (A1) and/or homopolymers (A2), at 30% to 90% by weight; one or more copolymer (B) selected from ethylene-alpha-olefin random copolymers (B1), hydrogenated styrene-ethylene-butadiene-styrene block copolymers (B2) and a combination of two or more of copolymers (B1) and/or copolymers (B2), at 0% to 50% by weight; one or more mineral filler (C) at 0% to 30% by weight; one or more surface modifier (D) at 0% to 5% by weight; one or more additive (E) at 0% to 5% by weight; and one or more colorant (F) at 0% to 10% by weight. Associated articles and methods are also described.2009-04-02
20090088511ELECTROLESS PLATING LIQUID - The electroless plating solution of the present invention is an electroless plating solution used for selectively forming a protective film on a surface of an exposed wiring in the production of a semiconductor device having a wiring structure, wherein 2009-04-02
20090088512Flame-retardant compounded polyester materials - The invention relates to flame-retardant compounded polyester materials, comprising as component A, from 40 to 64.9% by weight of thermoplastic polyester, as component B, from 5 to 10% by weight of polycarbonate, as component C, from 10 to 15% by weight of phosphinic salt of the formula (I) and/or diphosphinic salt of the formula (II), and/or polymers of these2009-04-02
20090088513RESIN ADDITIVE COMPOSITION AND RESIN COMPOSITION - A resin additive composition that includes a resin additive having a melting point of 100° C. or less and thereby is improved in handleability and is highly held in a resin is provided. The resin additive composition is prepared by impregnating a powdery inorganic material (B) having an oil absorption of 150 mL/100 g or more and preferably 200 mL/100 g or more with a resin additive (A) having a melting point of 100° C. or less in advance. Examples of the resin additive (A) include an antioxidant, an ultraviolet absorber, a light stabilizer, and mixtures thereof. Examples of the powdery inorganic material (B) include silica, aluminium silicate, hydrotalcite, calcium silicate, magnesium aluminometasilicate, and mixtures thereof.2009-04-02
20090088514POLYCARBONATE COMPOSITION HAVING IMPROVED IMPACT, FLAMMABILITY AND SURFACE APPEARANCE, METHOD OF MAKING, AND ARTICLES PREPARED THEREFROM - A thermoplastic composition comprises 55 to 97 weight percent of a polycarbonate; 1 to 25 weight percent of a polysiloxane-polycarbonate comprising siloxane units of the formula:2009-04-02
20090088515Glass Flake Filler, And Resin Composition Including The Same - A glass flake filler of the present invention is composed of glass flakes. The average thickness of the glass flakes is at least 0.1 μm but less than 0.5 μm, and the glass flakes include glass flakes having a thickness of at least 0.01 μm but not more than 2.0 μm in an amount of at least 90% by mass. A resin composition of the present invention is a resin composition including a thermoplastic resin and a glass flake filler. This glass flake filler is composed of glass flakes, the average thickness of the glass flakes is at least 0.1 μm but less than 0.5 μm, and the glass flakes include glass flakes having a thickness of at least 0.01 μm but not more than 2.0 μm in an amount of at least 90% by mass.2009-04-02
20090088516METHOD TO IMPROVE THE COLOR ACCEPTANCE OF VISCOSITY STABILIZED LATEX PAINTS - A system and method to improve the color acceptance of color viscosity stabilized latex paints. The system includes a base paint, 0.05 wt % to 5 wt % of a color viscosity stabilizing compound; a colorant compound, and; a sufficient amount of a hydrophobically modified alkali swellable emulsion (“HASE”) thickener to improve the color acceptance properties of the paint, which amount is typically 0.02 wt % to 0.5 wt % of the paint, and optionally, 0.1 wt % to 5 wt % of a condensation polymer associative thickener including polyether polyurethanes, polyether polyols, polyether polyacetals, and polyether aminoplasts. The system demonstrates improved color acceptance as measured by rub-ups and ΔE values.2009-04-02
20090088517CURING COMPOSITIONS FOR FLUOROPOLYMERS - A curative composition comprising a cation and an anion of the formula A2009-04-02
20090088518Polymers obtained via nitroxyl radical polymerization - Polymer of formula (I): In—[(A)2009-04-02
20090088519Furniture polish compositions substantially free of organic solvents - An easily spreadable furniture polish composition that provides dusting benefits and imparts shine with minimal residue to a surface to be treated. The furniture polish composition includes a film former, an aqueous carrier, an anionic associative polymer free of acrylates/C10-C30 alkyl acrylate crosspolymers, and is substantially free of organic solvents. In one embodiment, the anionic associative polymer is a hydrophobically-modified alkali-soluble emulsion polymer.2009-04-02
20090088520TIRE WITH A COMPONENT MADE OF A RUBBER COMPOSITION COMPRISED OF A RUBBER HAVING PENDANT HYDROXYL GROUPS AND A NONSULFUR CONTAINING SILANE - A tire with a rubber containing component compound of a copolymer rubber having pendant hydroxyl groups; and a non-sulfur containing silane.2009-04-02
20090088521AQUEOUS COLORANT DISPERSION, METHOD OF PRODUCING THE AQUEOUS COLORANT DISPERSION, AND AQUEOUS INK FOR INKJET RECORDING - The invention provides an aqueous colorant dispersion having: a colorant (A); a polymer (B); and an aqueous liquid medium (I), a method of producing the dispersion, and an aqueous ink for inkjet recording using the dispersion. The polymer (B) is a copolymer containing a hydrophilic structural unit and a hydrophobic structural unit. The hydrophobic structural unit contains a hydrophobic structural unit (a) containing a benzene ring which is not directly bonded to an atom that forms a main chain of the polymer (B). The hydrophilic structural unit contains a hydrophilic structural unit (b) containing an ionic group. The polymer (B) contains a structural unit (c) different from the hydrophobic structural unit (a) and the hydrophilic structural unit (b). A content of the hydrophobic structural unit and a content of the structural unit (c) with respect to a total mass of the polymer (B) are respectively in specific ranges.2009-04-02
20090088522EPDM Composition - The present invention is to provide an EPDM composition from which molding material excellent in low outgassing property and low gas permeability (low water vapor permeability) can be obtained even if the EPDM composition contains a mass of plasticizer blended in.2009-04-02
20090088523Room Temperature Curable Silicon Group-Containing Polymer Composition - Disclosed is a room temperature curable silicon group-containing polymer composition containing a reactive silicon group-containing polymer (A) having a group represented by the formula (1) at an end of the main chain, which is obtained through a reaction between a polyoxypropylene polyol and a γ-isocyanate propyltrialkoxysilane, a curing catalyst (B), an amino-functional organosiloxane (C), and optionally an inorganic filler (D) which is surface-treated with glycol. Also disclosed is a room temperature curable silicon group-containing polymer composition which contains, as the reactive silicon group-containing polymer (A), a mixture of a polymer (A1) having a reactive silicon-containing group at two or more ends, which is obtained through a reaction between a polyoxypropylene polyol and a γ-isocyanate propyltrialkoxysilane, and another polymer (A2) having a reactive silicon containing-group only at one end, which is obtained through a reaction between a hydroxypolyoxypropylene having a hydroxyl group at one end and a γ-isocyanate propyltrialkoxysilane, a curing catalyst (B) and an amino group-substituted alkoxysilane (C1) or an amino-functional organosiloxane (C2).2009-04-02
20090088524CURABLE SILICONE COMPOSITIONS - The present invention relates to silicone compositions which can be crosslinked thermally by hydrosilylation, a process for producing them, platinum catalysts used for this purpose and the use of the crosslinkable compositions.2009-04-02
20090088525Compositions Containing a Polyorganosiloxane Having One or More Piperidinyl Functions as a Protectant for Surfaces - Cleaning/protectant compositions containing a polyorganosiloxane having one or more piperidinyl functions are useful in the protection of vinyl, plastic and other hard surfaces from environmental exposure such as UV- or oxidation-induced damage.2009-04-02
20090088526COMPOSITION COMPRISING A COPOLYMER BASED ON ACRYLONITRILE AND A VINYLAROMATIC MONOMER, A COPOLYMER COMPRISING AT LEAST THREE BLOCKS AND A PARTICULATE COPOLYMER OF THE CORE-SHELL TYPE - The invention relates to an impact-resistant transparent composition comprising a copolymer having repeat units resulting from the polymerization of acrylonitrile and of at least one vinylaromatic monomer, a particulate block copolymer and a core-shell copolymer.2009-04-02
20090088527ATTACH PASTE COMPOSITION FOR SEMICONDUCTOR PACKAGE - The present invention relates to an attach paste composition for a semiconductor package. The attach paste composition for a semiconductor package includes a mixed resin, or a blend of an elastic resin and an epoxy resin as a basic resin. At this time, preferably the basic resin includes 50 to 95 weight % of the elastic resin and 5 to 50 weight % of the epoxy resin. The present invention enables a conventional semiconductor packaging method using a die adhesive to eliminate a pre-drying process performed after application of a die adhesive through screen printing and a thermal hardening process performed after an encapsulation process, maintains the properties of the die adhesive, ensures reliability of semiconductor products, and realizes a simple process.2009-04-02
20090088528Rubber Composition for Tire and Tire Using the Same - A rubber composition for a tire superior in grip performance and abrasion resistance and a tire prepared by using the same are provided. The rubber composition for a tire comprises 3 to 200 parts by weight of an aromatic vinyl polymer having an end modified with —OH, —SH, —COOH, —CSSH, —SO2009-04-02
20090088529FLUOROELASTOMERS - VDF-based curable fluoroelastomers, having a glass transition temperature lower than −49° C., preferably lower than −50° C., and having the following composition, as percent by moles: A) from 25% to 50%, preferably from 30% to 45%, of the monomer of formula: CF2=CFOCF2009-04-02
20090088530NOVEL POLYMER COMPOUND AND USES THEREOF - The present invention is related to novel polyolefin polymer compositions and methods of use thereof, in particular use in passenger and driver airbag cover applications for vehicles, wherein airbag covers are required to perform at extreme temperatures with no failures, brittle or ductile fractures. The polyolefin polymer includes: a first component having at least one polypropylene copolymer or homo propylene polymer present in the range of up to about 70% by weight of the polymer composition; a second component having at least one ethylene/octene copolymer present in the range of up to about 85% by weight of the polymer composition; and optionally, a third component having at least one metallocene elastomer comprising ethylene and a co-monomer. A method of forming an airbag cover from the polyolefin polymer is also described.2009-04-02
20090088531POLYMER COMPOSITIONS FOR REDUCED SHRINKAGE - A polymeric composition comprising a polymer and a nucleation agent, and having isotropic shrinkage of less than about 20% and a differential shrinkage of less than about 20%.2009-04-02
Website © 2025 Advameg, Inc.